Age, Tumor Size and Relative Survival of Patients With Localized Renal Cell Carcinoma: A Surveillance, Epidemiology and End Results Analysis

Journal of Urology

Volumn 181, Issue 2, 2009, Pages 506-511

  Scoll, Benjamin J ^a   Wong, Yu Ning ^b   Egleston, Brian L ^b   Kunkle, David A ^a   Saad, Ismail R ^a   Uzzo, Robert G ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

kidney neoplasms; mortality

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; DATA BASE; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; RACE; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; BIOPSY, NEEDLE; CARCINOMA, RENAL CELL; CAUSE OF DEATH; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; PROBABILITY; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS; TUMOR BURDEN;

EID: 58149187859     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.10.026     Document Type: Article

References (20)

1. Kattan M.W., Reuter V., Motzer R.J., Katz J., and Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166 (2001) 63
2. Frank I., Blute M.L., Cheville J.C., Lohse C.M., Weaver A.L., and Zincke H. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168 (2002) 2395
3. Zisman A., Pantuck A.J., Dorey F., Said J.W., Shvarts O., Quintana D., et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19 (2001) 1649
4. Campbell S.C., Novick A.C., and Bukowski R. Renal tumors. In: Wein A.J., Kavoussi L.R., Novick A.C., Partin A.W., and Peters C.A. (Eds). Campbell-Walsh Urology. 9th ed. Campbell-Walsh Urology vol 2 (2007), WB Saunders, Philadelphia 1567-1637 chapt 47
5. Jun C., Zhishun X., Xianzhou J., Qiang F., and Jin W. Association between age and clinical characteristics of renal cell carcinoma in adult patients. Int J Urol 13 (2006) 515
6. Sanchez-Ortiz R.F., Rosser C.J., Madsen L.T., Swanson D.A., and Wood C.G. Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma. J Urol 171 (2004) 2160
7. Eggener S.E., Rubenstein J.R., Smith N.D., Nadler R.B., Kontak J., Flanigan R.C., et al. Renal tumors in young adults. J Urol 171 (2004) 106
8. Denzinger S., Otto W., Burger M., Hammerschmied C., Junker K., Hartmann A., et al. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?. World J Surg Oncol 5 (2007) 16
9. Gillett M.D., Cheville J.C., Karnes R.J., Lohse C.M., Kwon E.D., Leibovich B.C., et al. Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses. J Urol 173 (2005) 1893
10. Taccoen X., Valeri A., Descotes J.L., Morin V., Stindel E., Doucet L., et al. Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol 51 (2007) 980
11. Goetzl M.A., Desai M., Mansukhani M., Goluboff E.T., Katz A.E., Sawczuk I.S., et al. Natural history and clinical outcome of sporadic renal cortical tumors diagnosed in the young adult. Urology 63 (2004) 41
12. Abou ElFettouh H.I., Cherullo E.E., El-Jack M., Al Maslamani Y., and Novick A.C. Sporadic renal cell carcinoma in young adults: presentation, treatment, and outcome. Urology 60 (2002) 806
13. Surveillance, Epidemiology, and End Results (SEER) program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 13 Regs Public-Use, Nov 2004 Sub (1973-2002 varying), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.
14. Brown C.C. The statistical comparison of relative survival rates. Biometrics 39 (1983) 941
15. Ficarra V., Guille F., Schips L., de la Taille A., Prayer Galetti T., Tostain J., et al. Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer 104 (2005) 2116
16. Gudbjartsson T., Hardarson S., Petursdottir V., Thoroddsen A., Magnusson J., and Einarsson G.V. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients. Eur Urol 48 (2005) 593
17. Patard J.J., Leray E., Rioux-Leclercq N., Cindolo L., Ficarra V., Zisman A., et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 23 (2005) 2763
18. Hollingsworth J.M., Miller D.C., Daignault S., and Hollenbeck B.K. Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis. Cancer 109 (2007) 1763
19. Begg C.B., and Schrag D. Attribution of deaths following cancer treatment. J Natl Cancer Inst 94 (2002) 1044
20. Pritt B.S., Hardin N.J., Richmond J.A., and Shapiro S.L. Death certification errors at an academic institution. Arch Pathol Lab Med 129 (2005) 1476